TP53 and cancer: Since TRIM26 has been shown to play both oncogenic and anti-oncogenic roles pending on types of cells and cancers (4, 6), we wondered if it might affect the growth of colorectal cancer (CRC) cells once we identified this protein as a potential p53-binding protein as described later in this report.